THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSİVE CARE PATIENTS UNDER MECHANICVENTILATION SUPPORT

NCT07632781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-06-08

No results posted yet for this study

Summary

The aim of this study is to examine the effect of Su Jok Therapy, applied to patients receiving mechanical ventilation support in the intensive care unit, on pain and physiological parameters.

Conditions

  • Intensive Care Unit Patients

Interventions

OTHER

su jok therapy group

In the intervention group, the reflex zones on the hands were identified with a probe. Buckwheat seeds were fixed to these areas with adhesive tape and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

OTHER

Placebo Group

In the placebo group, reflex zones on the hand were identified using a probe. Buckwheat seeds were fixed to a different area near these zones with a seed patch and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

Sponsors & Collaborators

  • Hasan Kalyoncu University

    lead OTHER

Principal Investigators

  • NERMİN OLGUN, Prof. Dr. · Hasan Kalyoncu University

  • MELTEM KALAYCI · Hasan Kalyoncu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-03-01
Completion
2025-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07632781 on ClinicalTrials.gov